ReShape Lifesciences Inc expected to post a loss of 17  cents a share - Earnings Preview

Vyome Holdings

25/03/2022 20:04

* ReShape Lifesciences Inc  RSLS.OQ   RSLS.O  is expected
to show
a rise in quarterly revenue when it reports  results on March
28. 
    * The San Clemente California-based  company is expected to
report
 a 6,030.3% increase in revenue to $3.74 million from $61
thousand a year ago, according to the mean estimate from 2
analysts, based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for ReShape
Lifesciences Inc
is for a loss of 17 cents per share. For the same quarter last
year, the company reported a loss of 51 cents per share.
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for ReShape
Lifesciences Inc is $9.13​, above​ its last closing price
of $1.28. ​​​

This summary was machine generated March 25 at 20:04 GMT.  All
figures in US dollars  unless otherwise stated